Inhibition of tetramethylpyrazine on Lewis lung carcinomas, microvessel growth and VEGF expression in mice

Chinese Pharmacological Bulletin

Volumn 20, Issue 2, 2004, Pages 151-154

  Xu, Xiao Yu ^a   Yan, Peng Ke ^a,b   Chen, Gang ^a   Liao, Duan Fang ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Lewis lung carcinomas; Microvessel density; Tetramethylpyrazine; Vascular endothelial growth factor

Indexed keywords

TETRAMETHYLPYRAZINE; VASCULOTROPIN;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; LEWIS CARCINOMA; MALE; METASTASIS; MICROVASCULATURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR VOLUME; WEIGHT; WESTERN BLOTTING;

EID: 1942440906     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Weidner N, Semple JP, Welch WR et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med, 1991;324(1):1-8
2. Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: Signalling pathways, biological response and therapeutic inhibtion. TiPS, 2001;22(4):201-4
3. Chan WY, Cheng RS, Yew DT. Postnatal changes of vascular endothelial growth factor (VEGF) expression in the retinae of normal and hypertensive rats. Life Science, 2000;66(17):1615 -25
4. Zhu Z, Witte L. Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endosthelial growth factor. Invest New Drugs, 1999;17(3):195-212
5. Melnyk O, Shuman MA, Kim KJ. Vascular endothelial growth factor promotes tumor dissemination by a mechanism distict from its effect on primary tumor growth. Cancer Res, 1996;56 (4):921-4
6. Toi M, Kondo S, Suzuki H et al. Qauntitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer, 1996;77(6):1101-6
7. Takigawa N, Segawa Y, Fujimoto N et al. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer. Anticancer Res, 1998;18(28):1251-4